Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2021-02-01 Regulatory Filings
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new product, Dr. Tobias Beta Blend, by Mimi’s Rock Corp. and Avivagen. It contains promotional content, product details, company background, and forward-looking statements. There is no financial data, regulatory filing references, or report attachments. It is not an earnings release, annual report, or any regulatory filing. It is a general corporate announcement about a product launch, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2021-02-01 English
Notice of the meeting and record date - French.pdf
Capital/Financing Update Classification · 100% confidence The document is titled as a "Pricing Supplement" related to a "Short Form Base Shelf Prospectus" and other prospectus supplements. It details the offering of securities under a Senior Note Program, including terms, risks, pricing, commissions, and legal disclaimers. The content is focused on the issuance and terms of a specific financial instrument (RBC Callable Yield Securities) and is structured as a prospectus supplement rather than a financial report or earnings release. There is no financial statement data, management discussion, or audit information. The document is a detailed offering document related to capital raising and securities issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-01-29 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a letter from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General Meeting (AGM) of Avivagen Inc. It provides details about the meeting type, record dates, meeting date, location, and proxy material handling. The document is short (1153 characters) and serves as a notification about the AGM logistics rather than the AGM materials or minutes themselves. It does not contain financial data, voting results, or detailed presentations. Therefore, it is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2021-01-29 English
Notice of the meeting and record date - French.pdf
AGM Information Classification · 95% confidence The document is a notification from Computershare to Canadian securities authorities regarding the upcoming Annual General Meeting (AGM) of Avivagen Inc. It provides details such as the type of meeting (Annual General Meeting), registration dates for receiving notice and voting, meeting date, and location. The document does not contain any financial data, management discussion, or detailed report content. It is essentially an announcement about the AGM logistics and shareholder meeting arrangements. Given the short length (1282 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including notices and meeting details.
2021-01-29 English
News release - English.pdf
Regulatory Filings
2021-01-27 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a $5 million bought deal unit offering by Avivagen Inc. It details the terms of the offering, including the number of units, pricing, warrants, use of proceeds, and regulatory approvals required. There is no financial statement or detailed financial analysis present, nor is this a report or transcript. The content clearly relates to a capital raising event and financing activity. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and the content is substantive, not merely an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2021-01-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.